From JAMA: Health Outcomes for post-meno, hysterectomized women on Premarin
 

http://jama.ama-assn.org/content/305/13/1305.full

"Conclusions. Among postmenopausal women with prior hysterectomy followed up for 10.7 years, CEE use for a median of 5.9 years was not associated with an increased or decreased risk of CHD, deep vein thrombosis, stroke, hip fracture, colorectal cancer, or total mortality. A decreased risk of breast cancer persisted."

Hopeful